Imbalances of Regional Pulmonary Ventilation in Patients With Post-acute-COVID-19

NCT ID: NCT05238623

Last Updated: 2025-09-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-10-01

Study Completion Date

2027-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Investigation of the correlation of CT-morphological changes of the lung compared to regional ventilation distribution on electrical impedance tomography in patients with post-acute-Covid-19 symptoms.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Prospective non-interventional, monocentric observational study on imbalances in regional lung ventilation compared to chest CT in post-acute-Covid-19. The aim is to verify the agreement between computerized tomography derived imaging variables and electrical impedance tomography in detecting lung ventilation imbalances. The primary study objective is to match CT morphological changes in regional ventilation in post-acute-COVID-19 patients and/or changes in lung function examination, with changes that can be visualized by electroimpedance tomography.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19 Pneumonia Post-acute COVID-19 Syndrome Electric Impedance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control cohort

lung-healthy volunteers get a EIT measurement

No interventions assigned to this group

Case cohort

Patients who receive standard CT and pulmonary function testing also receive electroimpedance tomography measurement

additional EIT Measurement

Intervention Type DIAGNOSTIC_TEST

Patients who receive standard CT and pulmonary function testing also receive electroimpedance tomography measurement. The lunghealthy Patients in the control group only receive a EIT.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

additional EIT Measurement

Patients who receive standard CT and pulmonary function testing also receive electroimpedance tomography measurement. The lunghealthy Patients in the control group only receive a EIT.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all patients undergoing a Chest CT due to suspected post-acute-Covid-19-syndrome
* \>18 years
* informed consent.

Exclusion Criteria

* trauma patients and patients with unstable spinal injuries or fractures
* patients with an BMI over 50
* patients with uncontrolled body movements
* Patients with a pacemaker
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jan-Christoph Lewejohann

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jan-Christoph Lewejohann

Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Phillip A Reuken, Dr.

Role: STUDY_DIRECTOR

Jena University Hospital, Klinik für Innere Medizin IV

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Klinik für Notfallmedizin

Jena, Thuringia, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jan-Christoph Lewejohann, Dr.

Role: CONTACT

+49 3641 9 32 20 13

Phillip A. Reuken, Dr.

Role: CONTACT

+49 3641 9 32 4504

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KIM-IV-EIT03

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.